Altimmune to Present at the 2021 Jefferies Virtual Healthcare Conference

GAITHERSBURG, Md., May 27, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. ALT, a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the 2021 Jefferies Virtual Healthcare Conference, being held June 1 - 4, 2021.

Details on the Jefferies fireside chat presentation are as follows:

 Title: 2021 Jefferies Virtual Healthcare Conference
    
 Presenters: Vipin Garg, Ph.D., Chief Executive Officer
   Scot Roberts, Ph.D., Chief Scientific Officer
   Scott Harris, M.D., Chief Medical Officer
    
 Date/Time: Wednesday, June 2, 2021 at 11:30 am ET

A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing intranasal vaccines, immune modulating therapies and treatments for liver disease. Our diverse pipeline includes proprietary intranasal vaccines for COVID-19 (AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an intranasal immune modulating therapeutic for COVID-19 (T-COVID™); and next generation peptide therapeutics for NASH (ALT-801) and chronic hepatitis B (HepTcell™). For more information on Altimmune, please visit www.altimmune.com.

Investor & Media Contacts:  
   
Will Brown Stacey Jurchison
Chief Financial Officer  Sr. Dir, Investor Relations
Phone: 240-654-1450 Phone : 410-474-8200
wbrown@altimmune.com sjurchison@altimmune.com



 



Primary Logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!